W

hen Sen. Bernie Sanders (I-Vt.) and Rep. Elijah Cummings (D-Md.) opened a probe into huge price hikes for some generic drugs two years ago, an attorney for Heritage Pharmaceuticals wrote the lawmakers that the company had not seen “any significant price increases” for its antibiotic. And Heritage declined to provide any documents.

Now, though, the lawmakers are having trouble believing that explanation.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.